Viewing Study NCT03990259


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-01-02 @ 6:43 AM
Study NCT ID: NCT03990259
Status: COMPLETED
Last Update Posted: 2019-06-18
First Post: 2019-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Penyagolosa Trail Saludable Women
Sponsor: Universitat Jaume I
Organization:

Study Overview

Official Title: Penyagolosa Trail Saludable Women
Status: COMPLETED
Status Verified Date: 2019-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PTSW
Brief Summary: This study has as main objective to asses different genetic, biochemical and physiological biomarkers affecting performance and health status in ultraendurance runners according to individual's sex.
Detailed Description: Ultraendurance races has been shown to impact on several health-related biomarkers, and therefore they may have detrimental effects on runners' health. In this study, we aim to analyze the impact of running a 107,6 km mountain race in ultraendurance runners splitting our sample by individual's sex.

To do this, baseline measurements of the runners have been collected through stress tests and biochemical analyses of blood and urine samples. Indeed, a saliva sample was collected to isolated a genomic DNA sample of each runner.

During the race anthropometrical, ventilatory and strength data was collected in three different moments and after crossing the finish line. Indeed, after completed the ultraendurance mountain race, blood and urine samples were taken at the finish line, as well as 24h and 48h post-race.

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: